Showing results (1971-1980 of 2,058) with videos related to
Sort By:
Pageof 206
The New England Journal of Medicine|August 3, 2022
Trial of Cinpanemab in Early Parkinson's DiseaseAnthony E Lang, Andrew D Siderowf, Eric A Macklin, et al.Cell Genomics|February 13, 2023
Retinal ganglion cell-specific genetic regulation in primary open-angle glaucomaMaciej Daniszewski, Anne Senabouth, Helena H Liang, et al.Ophthalmology|April 12, 2023
High Polygenic Risk Is Associated with Earlier Initiation and Escalation of Treatment in Early Primary Open-Angle GlaucomaHenry N Marshall, Sean Mullany, Xikun Han, et al.Bioorganic & Medicinal Chemistry Letters|September 5, 2024
Invention of novel 3-aminopiperidin-2-ones as calcitonin gene-related peptide receptor antagonistsDonnette D Staas, Ian M Bell, Christopher S Burgey, et al.Bioorganic & Medicinal Chemistry Letters|July 19, 2001
Evaluation of amino acid-based linkers in potent macrocyclic inhibitors of farnesyl-protein transferaseD C Beshore, I M Bell, C J Dinsmore, et al.Journal of Medicinal Chemistry|August 25, 2001
Design and biological activity of (S)-4-(5-([1-(3-chlorobenzyl)-2-oxopyrrolidin-3-ylamino]methyl)imidazol-1-ylmethyl)benzonitrile, a 3-aminopyrrolidinone farnesyltransferase inhibitor with excellent cell potencyI M Bell, S N Gallicchio, M Abrams, et al.Progress in Retinal and Eye Research|May 17, 2024
Alzheimer's disease pathophysiology in the RetinaBhakta Prasad Gaire, Yosef Koronyo, Dieu-Trang Fuchs, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 9, 2019
Emerging cerebrospinal fluid biomarkers in autosomal dominant Alzheimer's diseaseSuzanne E Schindler, Yan Li, Kaitlin W Todd, et al.Vaccine|March 14, 2022
Boosting of SARS-CoV-2 immunity in nonhuman primates using an oral rhabdoviral vaccineKah-Whye Peng, Timothy Carey, Patrycja Lech, et al.Acta Neuropathologica|February 11, 2023
Retinal pathological features and proteome signatures of Alzheimer's diseaseYosef Koronyo, Altan Rentsendorj, Nazanin Mirzaei, et al.Pageof 206